Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 18, 2026 17:50 ET | Source: B2Gold Corp.

B2Gold Reports Q4 and Full Year 2025 Results & 2026 Guidance; Achieved 2025 Gold Production and Cost Guidance; Record Annual Revenue in 2025 of Over $3 Billion; Gold Production for 2026 Anticipated to be Between 820,000 and 970,000 oz; Q1 2026 Dividend of US$0.02 Per Share Declared

VANCOUVER, British Columbia, Feb. 18, 2026 (GLOBE NEWSWIRE) -- B2Gold Corp. (TSX: BTO, NYSE AMERICAN: BTG, NSX: B2G) (“B2Gold” or the “Company”) announces its operational and financial results for...
February 18, 2026 09:00 ET | Source: Sprout Social, Inc

Sprout Social Launches AI-Powered Solutions and Expanded Reddit Partnership to Help Brands Navigate the Next Era of Discovery

An expanded Reddit partnership scales brand trust and discovery, enabling teams to authentically engage with Reddit communities directly from the Sprout platform.Recruit, a new AI-powered tool,...
February 18, 2026 08:00 ET | Source: Vaxart, Inc.

Vaxart to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 25, 2026

SOUTH SAN FRANCISCO, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company developing a range of oral vaccines based on its proprietary...
February 18, 2026 07:00 ET | Source: Aquestive Therapeutics, Inc.

Aquestive Therapeutics Appoints Internationally Recognized Allergist Dr. Matthew Greenhawt as Chief Medical Officer

Board-certified allergist and leading food allergy and anaphylaxis researcher joins Aquestive to support Anaphylm™ (dibutepinephrine) sublingual film NDA resubmission and pipeline WARREN, N.J., Feb. ...
February 17, 2026 09:00 ET | Source: Kaléo

Kaléo Marks 25 Years Advancing Drug Delivery Technology

Glen Allen, VA, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Kaléo, a global leader in drug-device combinations and auto-injector innovation, recognizes its 25th anniversary by celebrating the people, purpose,...
February 17, 2026 08:00 ET | Source: Nasus Pharma, Ltd.

Nasus Pharma to Present Data Highlighting Superior Nasal Deposition and Stability of Intranasal Epinephrine Powder at AAAAI 2026

TEL AVIV, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus Pharma" or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative...
February 13, 2026 09:00 ET | Source: Stansberry Asset Management, LLC

Stansberry Asset Management Celebrates Three-Year Anniversary of Tactical Select Strategy

Stansberry Asset Management marks three years of Tactical Select strategy, blending quantitative analysis and research to manage risk and drive growth.
February 13, 2026 08:00 ET | Source: Nasus Pharma, Ltd.

Nasus Pharma Announces Closing of $15.0 Million Private Placement

TEL AVIV, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus Pharma" or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative...
February 12, 2026 09:07 ET | Source: Canadian Foundation for Physically Disabled Persons

CFPDP to Honour Accessible Media Inc. (AMI), Granite REIT, Duncan Sinclair, David and Lynn Coriat, George Przybylowski, Prasanna Ranganathan and Tony Wight at 42nd Annual Great Valentine Gala

TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Canadian Foundation for Physically Disabled Persons (CFPDP) is pleased to announce the 2026 winners of the CFPDP Corporate Award, The Honourable David C....
February 12, 2026 07:00 ET | Source: PacBio

PacBio Joins iHope Initiative as First Long-Read Genomic Sequencing Partner

MENLO PARK, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, long-read sequencing technologies, today announced a collaboration with iHope, a...